Ketone BHB-BA
Natural health product licensed in Canada
- Other names
- KETONE Capsule, Ketone BHB-BA Capsule
- Licence holder
- Biologic Publishing Inc. also dba Biologic Nutrigenomic Health Research Corp.
- NPN or DIN-HM
- 80128426
- Status
- Active licence
- Licence date
- 6 December 2023
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Dose déclarée au-delà d'une limite
Chrome: up to 144 µg a day according to the dosing instructions published by Health Canada (12 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Potassium: up to 180.24 mg a day according to the dosing instructions published by Health Canada (12 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 80 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| D-3-Hydroxybutyrate Source : bêta-Hydroxybutyrate de Calcium | 435.3 mg | Not calculated |
| Dibutyrate de calcium Source : Calcium dibutyrate Potency : 76.9 % Butyric acid | 80 mg | Not calculated |
| Cinnamomum aromaticum Source : Cinnamomum aromaticum - Écorce de branche | 25 mg | Not calculated |
| Chrome Source : Nicotinate de chrome (III) | 12 microgram | 144 µg |
| Potassium Source : Citrate de potassium | 15.02 mg | 180,240 µg |
| 1,3,7-Triméthylxanthine Source : Camellia sinensis - feuille | 20 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Hypromellose, Cellulose microcristalline, Poudre d'enveloppes d'Oryza sativa (Riz), Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 6 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to maintain/support normal blood glucose levels. Helps to maintain/support the body's ability to metabolize nutrients. Provides support for healthy glucose metabolism. Source of/Provides antioxidants. Helps (temporarily) to promote alertness and wakefulness, and to enhance cognitive performance. Helps (temporarily) to support/promote mental sharpness/alertness. Helps (temporarily) to relieve fatigue, to promote endurance, and to enhance motor performance. Helps (temporarily) to enhance (physical) energy. Helps (temporarily) to reduce tiredness and fatigue. Provides/Source of beta-hydroxybutyrate that helps in/supports/contributes to energy production in the body. Source of/Provides (an) electrolyte(s).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80128426
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.